Many advances in the care of pwCF have been made since the publication of CFRD guidelines by the CFF, which suggests that additional research on CFRD and other CF‐related comorbidities in the era of CFTR modulator therapy is warranted.52 This evidence concerns the gene CFTR and cystic fibrosis.